Home/Filings/4/0001104659-25-061149
4//SEC Filing

Maraoui Claude 4

Accession 0001104659-25-061149

CIK 0001867066other

Filed

Jun 19, 8:00 PM ET

Accepted

Jun 20, 4:05 PM ET

Size

7.7 KB

Accession

0001104659-25-061149

Insider Transaction Report

Form 4
Period: 2025-06-17
Maraoui Claude
DirectorPresident & CEO
Transactions
  • Award

    Stock Option (Right to Buy)

    2025-06-17+82,91582,915 total
    Exercise: $6.31Exp: 2035-06-17Common Stock, $0.0001 par value (82,915 underlying)
  • Award

    Common Stock, $0.0001 par value

    2025-06-17+49,2772,397,590 total
Footnotes (3)
  • [F1]On June 17, 2025, the reporting person was granted 49,277 restricted stock units pursuant to the Issuer's 2015 Stock Plan, as amended, that will vest in accordance with the following schedule: 16,426 shares on January 1, 2026, 16,426 shares on January 1, 2027 and 16,425 shares on January 1, 2028.
  • [F2]Includes restricted stock units, which vest over various time periods.
  • [F3]On June 17, 2025, the reporting person was granted 82,915 stock options pursuant to the Issuer's 2015 Stock Plan, as amended, that will vest in accordance with the following schedule: 27,638 shares on January 1, 2026, 27,638 shares on January 1, 2027 and 27,639 shares on January 1, 2028.

Issuer

Journey Medical Corp

CIK 0001867066

Entity typeother

Related Parties

1
  • filerCIK 0001893880

Filing Metadata

Form type
4
Filed
Jun 19, 8:00 PM ET
Accepted
Jun 20, 4:05 PM ET
Size
7.7 KB